Mason Street Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Hold |
0
| – | -$1.63M | – | 838 |
|
|
2020
Q4 | – | Sell |
-6,383
| Closed | -$1.59M | – | 726 |
|
|
2020
Q3 | $1.59M | Sell |
6,383
-120
| -2% | -$29.9K | 0.03% | 630 |
|
|
2020
Q2 | $2.26M | Buy |
6,503
+265
| +4% | +$92.1K | 0.05% | 459 |
|
|
2020
Q1 | $1.67M | Hold |
6,238
| – | – | 0.04% | 517 |
|
|
2019
Q4 | $2.02M | Buy |
6,238
+4,573
| +275% | +$1.48M | 0.04% | 594 |
|
|
2019
Q3 | $455K | Buy |
1,665
+8
| +0.5% | +$2.19K | 0.01% | 1125 |
|
|
2019
Q2 | $884K | Buy |
1,657
+1
| +0.1% | +$533 | 0.02% | 903 |
|
|
2019
Q1 | $835K | Buy |
1,656
+29
| +2% | +$14.6K | 0.02% | 957 |
|
|
2018
Q4 | $802K | Buy |
1,627
+11
| +0.7% | +$5.42K | 0.02% | 877 |
|
|
2018
Q3 | $1.48M | Buy |
1,616
+109
| +7% | +$99.7K | 0.03% | 731 |
|
|
2018
Q2 | $1.1M | Buy |
1,507
+13
| +0.9% | +$9.52K | 0.02% | 838 |
|
|
2018
Q1 | $2.38M | Sell |
1,494
-1,236
| -45% | -$1.97M | 0.05% | 436 |
|
|
2017
Q4 | $2.45M | Buy |
2,730
+90
| +3% | +$80.6K | 0.05% | 417 |
|
|
2017
Q3 | $950K | Buy |
2,640
+89
| +3% | +$32K | 0.02% | 853 |
|
|
2017
Q2 | $748K | Buy |
2,551
+153
| +6% | +$44.9K | 0.02% | 890 |
|
|
2017
Q1 | $844K | Buy |
2,398
+172
| +8% | +$60.5K | 0.02% | 862 |
|
|
2016
Q4 | $410K | Buy |
2,226
+349
| +19% | +$64.3K | 0.01% | 1020 |
|
|
2016
Q3 | $484K | Buy |
1,877
+101
| +6% | +$26K | 0.01% | 942 |
|
|
2016
Q2 | $379K | Buy |
1,776
+165
| +10% | +$35.2K | 0.01% | 978 |
|
|
2016
Q1 | $332K | Buy |
1,611
+177
| +12% | +$36.5K | 0.01% | 982 |
|
|
2015
Q4 | $362K | Buy |
1,434
+134
| +10% | +$33.8K | 0.01% | 946 |
|
|
2015
Q3 | $214K | Buy |
1,300
+177
| +16% | +$29.1K | 0.01% | 1057 |
|
|
2015
Q2 | $211K | Buy |
+1,123
| New | +$211K | 0.01% | 1066 |
|